MDV3100 Drug targeting androgen receptor in BC

jenrio

MDV3100 Drug targeting androgen receptor in BC

jenrio

MDV3100 is a novel, orally administered small molecule

Phase I Clinical trial is recruiting:

http://abstract.asco.org/AbstView_114_100482.html

 

Another early trial for AR positive  TN cancer:

http://abstract.asco.org/AbstView_114_94715.html

 

mkkjd60

I think my fil is on this drug for prostate. Believe it is phase 3 for prostate and getting a lot of buzz. Thanks for posting.